股价飙升121%，摆脱“仙股”，健倍苗苗值得高看？

财华社12-05

近期，健倍苗苗（02161.HK）股价一路高歌猛进，从“仙股”摇身一变成港股“领涨先锋”。12月5日，健倍苗苗继续冲高，截至收盘，该股涨幅5.98%，报1.95港元/股，近60个交易日累计涨幅为121%。这一波涨幅的背后，主要得益于健倍苗苗亮眼业绩的推动。资料显示，健倍苗苗为医疗保健品推广及分销公司，旗下产品主要分为品牌药、健康保健品及品牌中药。其中，“保济丸”、“何济公止痛退热散”、“唐太宗活络...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2489539894?lang=zh_CN&edition=full","thumbnail":"https://images.finet.hk/photoLib/title/202412_1/594135e3-ef85-451b-a649-6fe5afc933ed.png","is_english":false,"pubTime":"2024-12-05 20:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2489539894","market":"hk","top_or_hot":-1,"title":"股价飙升121%，摆脱“仙股”，健倍苗苗值得高看？","media":"财华社","content":"<div>\n<p>近期，健倍苗苗（02161.HK）股价一路高歌猛进，从“仙股”摇身一变成港股“领涨先锋”。12月5日，健倍苗苗继续冲高，截至收盘，该股涨幅5.98%，报1.95港元/股，近60个交易日累计涨幅为121%。这一波涨幅的背后，主要得益于健倍苗苗亮眼业绩的推动。资料显示，健倍苗苗为医疗保健品推广及分销公司，旗下产品主要分为品牌药、健康保健品及品牌中药。其中，“保济丸”、“何济公止痛退热散”、“唐太宗活络...</p>\n\n<a href=\"https://www.finet.hk/newscenter/news_content/67519ad1bde0b340822c3bf4\">网页链接</a>\n\n</div>\n","source":"finet_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>股价飙升121%，摆脱“仙股”，健倍苗苗值得高看？</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n股价飙升121%，摆脱“仙股”，健倍苗苗值得高看？\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-05 20:21 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.finet.hk/newscenter/news_content/67519ad1bde0b340822c3bf4><strong>财华社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近期，健倍苗苗（02161.HK）股价一路高歌猛进，从“仙股”摇身一变成港股“领涨先锋”。12月5日，健倍苗苗继续冲高，截至收盘，该股涨幅5.98%，报1.95港元/股，近60个交易日累计涨幅为121%。这一波涨幅的背后，主要得益于健倍苗苗亮眼业绩的推动。资料显示，健倍苗苗为医疗保健品推广及分销公司，旗下产品主要分为品牌药、健康保健品及品牌中药。其中，“保济丸”、“何济公止痛退热散”、“唐太宗活络...</p>\n\n<a href=\"https://www.finet.hk/newscenter/news_content/67519ad1bde0b340822c3bf4\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1606","symbol_name":"中医药概念","start_time":0,"source_url":"https://www.finet.hk/newscenter/news_content/67519ad1bde0b340822c3bf4","article_id":"2489539894","we_media_id":null,"thumbnails":["https://images.finet.hk/photoLib/title/202412_1/594135e3-ef85-451b-a649-6fe5afc933ed.png"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2489539894","pubTimestamp":1733401297,"columns":[],"sourceInfo":{"source_id":"finet_stock","name":"财华社"},"weMediaInfo":null,"summary":"近期，健倍苗苗（02161.HK）股价一路高歌猛进，从“仙股”摇身一变成港股“领涨先锋”。","collect":0,"end_time":0,"defaultTopTitle":"finet.hk","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1606":"中医药概念","02161":"健倍苗苗","BK1191":"制药"},"translate_title":"The stock price soared 121%, getting rid of the \"penny stock\", is Jianbei Miaomiao worth watching?","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02161":1},"content_text":"近期，健倍苗苗（02161.HK）股价一路高歌猛进，从“仙股”摇身一变成港股“领涨先锋”。12月5日，健倍苗苗继续冲高，截至收盘，该股涨幅5.98%，报1.95港元/股，近60个交易日累计涨幅为121%。这一波涨幅的背后，主要得益于健倍苗苗亮眼业绩的推动。资料显示，健倍苗苗为医疗保健品推广及分销公司，旗下产品主要分为品牌药、健康保健品及品牌中药。其中，“保济丸”、“何济公止痛退热散”、“唐太宗活络油”、“飞鹰活络油”、“十灵丹”等一系列家喻户晓的品牌医疗保健品等都在该公司旗下。近年来，随着全球经济逐步复苏和公众健康意识的日益提高，健康和医疗行业呈现出明显的增长趋势，这使得投资者对相关企业抱有更高的期望，健倍苗苗的表现正好符合这一市场预期。11月1日，健倍苗苗发布2025财年中期业绩盈喜公告。盈喜消息极大提振了市场情绪。当天，公司股价在午后交易中迅速拉升，收盘时涨幅扩大至21.87%。11月19日，健倍苗苗发布了2025年财年中期业绩报告，进一步增强了投资者的信心，该股继续攀升。11月以来，该股累计涨幅达到了103.13%。据财报显示，健倍苗苗收益约为3.99亿港元，同比增加约22.1%；归母净利润约为9590万港元，同比增加约53.4%。此外，每股盈利11.63港仙，中期股息每股5.5港仙。对于业绩的大幅增长，这主要受惠于健倍苗苗核心品牌的出色销售表现。报告期内，在“何济公”产品带动下，品牌药分部收益取得23.9%的可观增长。品牌中药分部收益整体增长17.9%，主要得益于“保济丸”的可观增长，及浓缩中药颗粒业务的持续强劲势头。健康保健品分部的销售额亦保持稳定的增长势头，同比增速达38.9%，令人鼓舞。健倍苗苗表示，此等佳绩也反映公司成功实施线上及线下渠道一体化销售及营销策略，从而有效把握消费保健产品于香港、澳门及大湾区内城市市场的增长机遇。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2489539894"}